Quality assessment of global clinical practice guidelines for transplantation in 2017_Chinese Journal of Evidence-Based Medicine

Authors：

 ZHU Zhijun ^1,2 , SUN Liying ^1,2 , ZHANG Haiming ^1,2 , SHI Yuexian ³

1. Liver Transplantation Center, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, P.R.China;
2. National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, P.R.China;
3. School of Nursing, Peking University, Beijing, 100191, P.R.China;

Corresponding author：

ZHU Zhijun, Email: zhu-zhijun@outlook.com

Keywords：

Transplantation; Clinical practice guideline; Quality assessment; AGREE Ⅱ

DOI：

10.7507/1672-2531.201805093

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

ObjectivesTo assess the quality of clinical practice guidelines for transplantation in 2017. MethodsPubMed, NICE, NGC, NCCN, SIGN, CMA Infobase and GIN databases were searched online to collect guidelines for transplantation published in 2017. Guidelines were then assessed by using the AGREE Ⅱ instrument. ResultsA total of 10 guidelines were included. The result of assessments by the AGREE Ⅱ instrument showed a clear discrepancy among domains (P=0.001). Satisfactory scores were found in domains of " scope and purpose”, " clarity of presentation” and " overall score”, where the average scores were 90.8% (95%CI 83.5% to 98.1%), 82.5% (95%CI 72.7% to 92.3%) and 75.6% (95%CI 66.6% to 84.6%), respectively. Low scores were found in domains of " stakeholder involvement” and " applicability”, in which a score of 40.0% (95%CI 32.4% to 47.6%) and a score of 27.8% (95%CI 11.2% to 44.5%) were achieved, respectively. ConclusionsThere is a clear discrepancy among domains of global clinical practice guidelines for transplantation in 2017. Guidelines in this field should be improved in " stakeholder involvement” and " applicability”.

Citation： ZHU Zhijun, SUN Liying, ZHANG Haiming, SHI Yuexian. Quality assessment of global clinical practice guidelines for transplantation in 2017. Chinese Journal of Evidence-Based Medicine, 2018, 18(9): 964-968. doi: 10.7507/1672-2531.201805093 Copy

1.	朱志军, 曾志贵. 儿童肝移植术后早期血管并发症的诊断、治疗及预防. 中国普外基础与临床杂志, 2015, 22(12): 1425-1427.
2.	曲伟, 孙丽莹, 朱志军, 等. CD4+T 细胞-iATP 在监测肝脏移植术后感染性疾病的有效性. 中华实验外科杂志, 2015, 32(10): 2419.
3.	孙丽莹, 朱志军, 魏林, 等. 肝移植治疗儿童遗传代谢性疾病 42 例. 中华器官移植杂志, 2017, 38(6): 337-342.
4.	朱志军. 小肝综合征的防治策略与进展. 中国普外基础与临床杂志, 2017, 24(8): 923-926.
5.	陈虹, 张庆, 张文学, 等. 肝移植术后中远期肺部真菌感染. 中华医院感染学杂志, 2009, 19(16): 2096-2098.
6.	陈虹, 王旭, 张庆, 等. 肝移植术后中远期黄疸的原因分析与治疗. 中华器官移植杂志, 2012, 33(2): 97-100.
7.	霍枫. 公民心脏死亡器官捐献开启我国器官移植新时代. 器官移植, 2013, 4(5): 247-249.
8.	姜贤飞, 朱方, 刘琴, 等. 我国器官移植立法存在的问题与思考. 中国循证医学杂志, 2010, 10(11): 1353-1355.
9.	曹林平, 吴健. 肝癌肝移植受体的选择标准. 中华肝脏病杂志, 2018, 26(2): 84-87.
10.	Mitka M. Groups aim for trustworthy clinical practice guidelines. JAMA, 2014, 311(12): 1187-1188.
11.	Appraisal of guidelines for research & evaluation Ⅱ instrument. Available at: https://www.agreetrust.org/wp-content/uploads/2017/12/AGREE-Ⅱ-Users-Manual-and-23-item-Instrument-2009-Update-2017.pdf.
12.	Dietz AC, Savage SA, Vlachos A, et al. Late effects screening guidelines after hematopoietic cell transplantation for inherited bone marrow failure syndromes: consensus statement from the second pediatric blood and marrow transplant consortium international conference on late effects after pediatric HCT. Biol Blood Marrow Transplant, 2017, 23(9): 1422-1428.
13.	Lehrnbecher T, Robinson P, Fisher B, et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol, 2017, 35(18): 2082-2094.
14.	Miller CM, Quintini C, Dhawan A, et al. The international liver transplantation society living donor liver transplant recipient guideline. Transplantation, 2017, 101(5): 938-944.
15.	Artificial heart implantation as a bridge to transplantation for end-stage refractory biventricular heart failure. Available at: https://www.nice.org.uk/guidance/ipg602/chapter/1-Recommendations.
16.	Immunosuppressive therapy for kidney transplant in adults. Available at: https://www.nice.org.uk/guidance/ta481.
17.	Immunosuppressive therapy for kidney transplant in children and young people. Available at: https://www.nice.org.uk/guidance/ta482.
18.	Kharfan-Dabaja MA, Kumar A, Ayala E, et al. Clinical practice recommendations on indication and timing of hematopoietic cell transplantation in mature T cell and NK/T cell lymphomas: an international collaborative effort on behalf of the guidelines committee of the American society for blood and marrow transplantation. Biol Blood Marrow Transplant, 2017, 23(11): 1826-1838.
19.	Sung L, Robinson P, Treister N, et al. Guideline for the prevention of oral and oropharyngeal mucositis in children receiving treatment for cancer or undergoing haematopoietic stem cell transplantation. BMJ Support Palliat Care, 2017, 7(1): 7-16.
20.	Silla L, Dulley F, Saboya R, et al. Brazilian guidelines on hematopoietic stem cell transplantation in acute myeloid leukemia. Eur J Haematol, 2017, 98(2): 177-183.
21.	Ko BS, Chen WT, Kung HC, et al. 2016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan. J Microbiol Immunol Infect, 2018, 51(3): 287-301.
22.	江梅, 廖理粤, 罗炜, 等. 国内咳嗽诊疗指南的质量评价. 中国循证医学杂志, 2015, 15(4): 409-413.
23.	Choi TY, Choi J, Lee JA, et al. The quality of clinical practice guidelines in traditional medicine in Korea: appraisal using the AGREE II instrument. Implement Sci, 2015, 10: 104.
24.	李楠, 姚亮, 吴琼芳, 等. 2012~2013 年中国大陆期刊发表临床实践指南质量评价. 中国循证医学杂志, 2015, 15(3): 259-263.

1. 朱志军, 曾志贵. 儿童肝移植术后早期血管并发症的诊断、治疗及预防. 中国普外基础与临床杂志, 2015, 22(12): 1425-1427.
2. 曲伟, 孙丽莹, 朱志军, 等. CD4+T 细胞-iATP 在监测肝脏移植术后感染性疾病的有效性. 中华实验外科杂志, 2015, 32(10): 2419.
3. 孙丽莹, 朱志军, 魏林, 等. 肝移植治疗儿童遗传代谢性疾病 42 例. 中华器官移植杂志, 2017, 38(6): 337-342.
4. 朱志军. 小肝综合征的防治策略与进展. 中国普外基础与临床杂志, 2017, 24(8): 923-926.
5. 陈虹, 张庆, 张文学, 等. 肝移植术后中远期肺部真菌感染. 中华医院感染学杂志, 2009, 19(16): 2096-2098.
6. 陈虹, 王旭, 张庆, 等. 肝移植术后中远期黄疸的原因分析与治疗. 中华器官移植杂志, 2012, 33(2): 97-100.
7. 霍枫. 公民心脏死亡器官捐献开启我国器官移植新时代. 器官移植, 2013, 4(5): 247-249.
8. 姜贤飞, 朱方, 刘琴, 等. 我国器官移植立法存在的问题与思考. 中国循证医学杂志, 2010, 10(11): 1353-1355.
9. 曹林平, 吴健. 肝癌肝移植受体的选择标准. 中华肝脏病杂志, 2018, 26(2): 84-87.
10. Mitka M. Groups aim for trustworthy clinical practice guidelines. JAMA, 2014, 311(12): 1187-1188.
11. Appraisal of guidelines for research & evaluation Ⅱ instrument. Available at: https://www.agreetrust.org/wp-content/uploads/2017/12/AGREE-Ⅱ-Users-Manual-and-23-item-Instrument-2009-Update-2017.pdf.
12. Dietz AC, Savage SA, Vlachos A, et al. Late effects screening guidelines after hematopoietic cell transplantation for inherited bone marrow failure syndromes: consensus statement from the second pediatric blood and marrow transplant consortium international conference on late effects after pediatric HCT. Biol Blood Marrow Transplant, 2017, 23(9): 1422-1428.
13. Lehrnbecher T, Robinson P, Fisher B, et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol, 2017, 35(18): 2082-2094.
14. Miller CM, Quintini C, Dhawan A, et al. The international liver transplantation society living donor liver transplant recipient guideline. Transplantation, 2017, 101(5): 938-944.
15. Artificial heart implantation as a bridge to transplantation for end-stage refractory biventricular heart failure. Available at: https://www.nice.org.uk/guidance/ipg602/chapter/1-Recommendations.
16. Immunosuppressive therapy for kidney transplant in adults. Available at: https://www.nice.org.uk/guidance/ta481.
17. Immunosuppressive therapy for kidney transplant in children and young people. Available at: https://www.nice.org.uk/guidance/ta482.
18. Kharfan-Dabaja MA, Kumar A, Ayala E, et al. Clinical practice recommendations on indication and timing of hematopoietic cell transplantation in mature T cell and NK/T cell lymphomas: an international collaborative effort on behalf of the guidelines committee of the American society for blood and marrow transplantation. Biol Blood Marrow Transplant, 2017, 23(11): 1826-1838.
19. Sung L, Robinson P, Treister N, et al. Guideline for the prevention of oral and oropharyngeal mucositis in children receiving treatment for cancer or undergoing haematopoietic stem cell transplantation. BMJ Support Palliat Care, 2017, 7(1): 7-16.
20. Silla L, Dulley F, Saboya R, et al. Brazilian guidelines on hematopoietic stem cell transplantation in acute myeloid leukemia. Eur J Haematol, 2017, 98(2): 177-183.
21. Ko BS, Chen WT, Kung HC, et al. 2016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan. J Microbiol Immunol Infect, 2018, 51(3): 287-301.
22. 江梅, 廖理粤, 罗炜, 等. 国内咳嗽诊疗指南的质量评价. 中国循证医学杂志, 2015, 15(4): 409-413.
23. Choi TY, Choi J, Lee JA, et al. The quality of clinical practice guidelines in traditional medicine in Korea: appraisal using the AGREE II instrument. Implement Sci, 2015, 10: 104.
24. 李楠, 姚亮, 吴琼芳, 等. 2012~2013 年中国大陆期刊发表临床实践指南质量评价. 中国循证医学杂志, 2015, 15(3): 259-263.

Previous Article
Efficacy of Chinese herbal medicine combined with chemotherapy for ovarian cancer: a systematic review
Next Article
The importance of dissemination of evidence-based medicine to right care

Chinese Journal of Evidence-Based Medicine

Quality assessment of global clinical practice guidelines for transplantation in 2017

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content